Uploaded July 2026 | Updated September 2026, 3 hours ago
Lung Foundation Australia, in collaboration with the Centre of Research Excellence in Pulmonary Fibrosis present the pulmonary fibrosis clinical trials webinar. The webinar explores how clinical trials are conducted in stages. Phase 1 trials assess whether a new drug is safe. Phase 2 trials explore whether it works in people with the disease. Phase 3 trials involve larger groups to compare new treatments with standard care. Many studies also include an open-label extension, where all participants receive the study drug to assess long-term benefits and safety.
Lung Foundation Australia, in collaboration with the Centre of Research Excellence in Pulmonary Fibrosis present the pulmonary fibrosis clinical trials webinar. The webinar explores how clinical trials are conducted in stages. Phase 1 trials assess whether a new drug is safe. Phase 2 trials explore whether it works in people with the disease. Phase 3 trials involve larger groups to compare new treatments with standard care. Many studies also include an open-label extension, where all participants receive the study drug to assess long-term benefits and safety.
